Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple.
OBJECTIVE
The detection of low/intermediate/high risk genital groups of human papillomavirus (HPV) in correlation with a growth-factor receptor c-erbB-2 in benign tumors of the mammary nipple.


METHODS
Ten nipple duct adenomas (NDAs) and twenty papillomas, all embedded in paraffin and taken from the breast, were analyzed for HPV DNA of the low- and high/intermediate-risk groups. Polymerase chain reaction (PCR) with HPV consensus primers (types 6/11/16/18/33) and dot-blot hybridization with type-specific primers were used for the detection of these HPV-DNA sequences. Indirect in situ PCR (ISPCR) was also used in one case of an HPV-DNA-positive papilloma. In addition, we examined c-erbB-2 oncogene expression in NDAs and central carcinomas of the mamma from an immunohistochemical perspective.


RESULTS
Using PCR and dot-blot hybridization we could not detect the gene sequences that are specific for the low- and high/intermediate-risk groups in any of the ten NDAs. Regarding the 20 cases of papilloma, a positive result for HPV types 6/11 was detected by indirect ISPCR; in one case in combination with a condyloma of the skin around the mammary nipple. The oncogene expression of c-erbB-2 displayed a strong signal in the papilloma cells and in the NDAs of the breast.


CONCLUSIONS
Our results showed that the HPV-DNA types of the low- and high/intermediate-risk groups are without relevance for the pathogenesis of benign diseases of the nipple. It was, therefore, not possible to establish a correlation between the oncogene expression of c-erbB-2 and the HPV-DNA types.
Manavi
M
M
Department of Obstetrics and Gynecology, Division of Special Gynecology, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Mahmood.Manavi@akh-wien.ac.at
Baghestanian
M
M
Kucera
E
E
Berger
A
A
Schatten
C
C
Pischinger
K
K
Czerwenka
K
K
D000236:Adenoma / Q000235:genetics / Q000473:pathology / Q000821:virology*; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology / Q000821:virology*; D015344:DNA Probes, HPV; D004279:DNA, Viral / Q000302:isolation & purification; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D009558:Nipples / Q000821:virology; D009693:Nucleic Acid Hybridization; D010212:Papilloma / Q000235:genetics / Q000473:pathology / Q000821:virology*; D027383:Papillomaviridae / Q000145:classification / Q000302:isolation & purification* / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000821:virology*; D016133:Polymerase Chain Reaction; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D012306:Risk; D014412:Tumor Virus Infections / Q000453:epidemiology / Q000821:virology*
D015344:DNA Probes, HPV; D004279:DNA, Viral; D018719:Erb-b2 Receptor Tyrosine Kinases